Filters
reset allOther countries
Results: 1 to 17 of 17
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene AG - the Rare Disease Company Germany | 155 | 107 |
|
PIK3CA - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 14 | 1 |
|
Polydactyly and Syndactyly Panel PreventionGenetics, part of Exact Sciences United States | 320 | 231 |
|
PreventionGenetics, part of Exact Sciences United States | 220 | 128 |
|
PreventionGenetics, part of Exact Sciences United States | 48 | 28 |
|
Overgrowth and Macrocephaly Syndromes Panel PreventionGenetics, part of Exact Sciences United States | 145 | 112 |
|
Cowden and Cowden-like Syndromes via the PIK3CA Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 122 | 117 |
|
Megalencephaly-Capillary Malformation Syndrome (PIK3CA Single Gene Test) Fulgent Genetics United States | 12 | 1 |
|
Neuronal Migration Disorders NGS Panel Fulgent Genetics United States | 392 | 83 |
|
Klippel-Trenaunay Syndrome (PIK3CA Single Gene Test) Fulgent Genetics United States | 12 | 1 |
|
Macrocephaly/Overgrowth Syndrome NGS Panel Fulgent Genetics United States | 100 | 38 |
|
Congenital Heart Defect NGS Panel Fulgent Genetics United States | 377 | 114 |
|
Laboratorio de Genetica Clinica SL Spain | 4 | 9 |
|
Fulgent Genetics United States | 12 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Cancer Genomic Medicine Translational Research Lab Cleveland Clinic Genomic Medicine Institute United States | 11 | 1 |
|
Results: 1 to 17 of 17
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.